Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GaiaGift is a U.S.-based birth tissue donation and collection company that sources umbilical cord blood, placental tissue, and umbilical cord tissue for medical research and regenerative medicine development. The company operates as a wholly owned subsidiary of OrganaBio and serves as part of OrganaBio's cell and gene therapy supply chain infrastructure. GaiaGift focuses on donor recruitment, consent, ethical collection, and rapid delivery of birth tissue-derived materials to researchers and therapeutics developers. Its activities support discovery and clinical development programs in areas such as cancer, autoimmune, cardiovascular, and neurological disease rather than advancing proprietary drug candidates of its own. The business appears to be commercial-stage as a tissue procurement and enabling-services company, not a clinical-stage therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GaiaGift.